Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
- 24 September 1988
- Vol. 297 (6651), 772-773
- https://doi.org/10.1136/bmj.297.6651.772
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Effects of Transforming Growth Factor-β on Osteoblastic Osteosarcoma Cells*Endocrinology, 1987
- Value of CA 15:3 in the follow-up of breast cancer patientsBritish Journal of Cancer, 1987
- Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.Proceedings of the National Academy of Sciences of the United States of America, 1986